Nuzenio

Neuphoria

Neuphoria news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Neuphoria Therapeutics Inc (NEUP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 09:02:03 GMTAre CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders? - TradingViewTradingView · Tue, 04 Aug 2026 20:40:00 GMTBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc. (Nasdaq – SAFT), Neuphoria Therape - The Daily Tribune NewsThe Daily Tribune News · Tue, 04 Aug 2026 16:13:27 GMTScancell merges with Nasdaq shell Neuphoria to fund USD 89m Phase III melanoma trial - AllSciAllSci · Fri, 31 Jul 2026 15:25:48 GMTNEUP|Neuphoria Therapeutics Inc|Price:3.880|Chg%:-0.040 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTNeuphoria Therapeutics Inc (NEUP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTAdvising Nasdaq-listed Neuphoria Therapeutics Inc. on its USD250M merger with AIM-listed Scancell Holdings - Winston TaylorWinston Taylor · Wed, 29 Jul 2026 03:25:29 GMT

Timeline

Fri, 07 Aug 2026 09:02:03 GMTNeuphoria Therapeutics Inc (NEUP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tue, 04 Aug 2026 20:40:00 GMTAre CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders? - TradingView
Tue, 04 Aug 2026 16:13:27 GMTBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc. (Nasdaq – SAFT), Neuphoria Therape - The Daily Tribune News
Fri, 31 Jul 2026 15:25:48 GMTScancell merges with Nasdaq shell Neuphoria to fund USD 89m Phase III melanoma trial - AllSci
Fri, 31 Jul 2026 07:00:00 GMTNEUP|Neuphoria Therapeutics Inc|Price:3.880|Chg%:-0.040 - TradingKey
Fri, 31 Jul 2026 07:00:00 GMTNeuphoria Therapeutics Inc (NEUP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neuphoria.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.